266 related articles for article (PubMed ID: 29114858)
1. Midlife metabolic factors and prostate cancer risk in later life.
Dickerman BA; Torfadottir JE; Valdimarsdottir UA; Wilson KM; Steingrimsdottir L; Aspelund T; Batista JL; Fall K; Giovannucci E; Sigurdardottir LG; Tryggvadottir L; Gudnason V; Markt SC; Mucci LA
Int J Cancer; 2018 Mar; 142(6):1166-1173. PubMed ID: 29114858
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
[TBL] [Abstract][Full Text] [Related]
3. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Hammarsten J; Högstedt B
Blood Press; 2004; 13(1):47-55. PubMed ID: 15083641
[TBL] [Abstract][Full Text] [Related]
4. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
5. Prospective study on metabolic factors and risk of prostate cancer.
Häggström C; Stocks T; Ulmert D; Bjørge T; Ulmer H; Hallmans G; Manjer J; Engeland A; Nagel G; Almqvist M; Selmer R; Concin H; Tretli S; Jonsson H; Stattin P
Cancer; 2012 Dec; 118(24):6199-206. PubMed ID: 23090855
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study.
De Nunzio C; Simone G; Brassetti A; Mastroianni R; Collura D; Muto G; Gallucci M; Tubaro A
BMC Cancer; 2016 Jul; 16():407. PubMed ID: 27386844
[TBL] [Abstract][Full Text] [Related]
7. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
8. A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer.
Hammarsten J; Damber JE; Peeker R; Mellström D; Högstedt B
Cancer Epidemiol; 2010 Oct; 34(5):574-9. PubMed ID: 20702155
[TBL] [Abstract][Full Text] [Related]
9. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy.
De Nunzio C; Freedland SJ; Miano R; Trucchi A; Cantiani A; Carluccini A; Tubaro A
Prostate; 2011 Oct; 71(14):1492-8. PubMed ID: 21360562
[TBL] [Abstract][Full Text] [Related]
11. Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway.
Martin RM; Vatten L; Gunnell D; Romundstad P; Nilsen TI
Cancer Causes Control; 2009 Sep; 20(7):1181-92. PubMed ID: 19277881
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome increases the risk of upgrading and upstaging in patients with prostate cancer on biopsy: a radical prostatectomy multicenter cohort study.
De Nunzio C; Brassetti A; Simone G; Lombardo R; Mastroianni R; Collura D; Muto G; Gallucci M; Tubaro A
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):438-445. PubMed ID: 29867154
[TBL] [Abstract][Full Text] [Related]
13. Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.
Bonn SE; Sjölander A; Tillander A; Wiklund F; Grönberg H; Bälter K
Int J Cancer; 2016 Jul; 139(1):50-7. PubMed ID: 26914149
[TBL] [Abstract][Full Text] [Related]
14. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort Study.
Zhang M; Wang B; Liu Y; Sun X; Luo X; Wang C; Li L; Zhang L; Ren Y; Zhao Y; Zhou J; Han C; Zhao J; Hu D
Cardiovasc Diabetol; 2017 Mar; 16(1):30. PubMed ID: 28249577
[TBL] [Abstract][Full Text] [Related]
15. Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
Murtola TJ; Vihervuori VJ; Lahtela J; Talala K; Taari K; Tammela TL; Auvinen A
Br J Cancer; 2018 May; 118(9):1248-1254. PubMed ID: 29563633
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort.
Stocks T; Hergens MP; Englund A; Ye W; Stattin P
Int J Cancer; 2010 Oct; 127(7):1660-8. PubMed ID: 20087861
[TBL] [Abstract][Full Text] [Related]
17. Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican men.
Salgado-Montilla J; Soto Salgado M; Surillo Trautmann B; Sánchez-Ortiz R; Irizarry-Ramírez M
Lipids Health Dis; 2015 Sep; 14():111. PubMed ID: 26377420
[TBL] [Abstract][Full Text] [Related]
18. Body fat distribution on computed tomography imaging and prostate cancer risk and mortality in the AGES-Reykjavik study.
Dickerman BA; Torfadottir JE; Valdimarsdottir UA; Giovannucci E; Wilson KM; Aspelund T; Tryggvadottir L; Sigurdardottir LG; Harris TB; Launer LJ; Gudnason V; Markt SC; Mucci LA
Cancer; 2019 Aug; 125(16):2877-2885. PubMed ID: 31179538
[TBL] [Abstract][Full Text] [Related]
19. Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer: a single biopsy cohort analysis.
De Nunzio C; Truscelli G; Trucchi A; Petta S; Tubaro M; Gacci M; Gaudio C; Presicce F; Tubaro A
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):35-9. PubMed ID: 26439746
[TBL] [Abstract][Full Text] [Related]
20. The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study.
Ding C; Yang Z; Wang S; Sun F; Zhan S
Endocrine; 2018 May; 60(2):282-291. PubMed ID: 29492904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
